- Home
- AGEN vs AZI Comparison
AGEN vs AZI Comparison
Compare AGEN & AZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- AZI
- Stock Information
- Founded
- AGEN 1994
- AZI 2010
- Country
- AGEN United States
- AZI China
- Employees
- AGEN N/A
- AZI N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- AZI
- Sector
- AGEN Health Care
- AZI
- Exchange
- AGEN Nasdaq
- AZI Nasdaq
- Market Cap
- AGEN 96.2M
- AZI 98.3M
- IPO Year
- AGEN 2000
- AZI 2024
- Fundamental
- Price
- AGEN $2.86
- AZI $1.90
- Analyst Decision
- AGEN Buy
- AZI
- Analyst Count
- AGEN 3
- AZI 0
- Target Price
- AGEN $9.33
- AZI N/A
- AVG Volume (30 Days)
- AGEN 576.6K
- AZI 2.2M
- Earning Date
- AGEN 11-12-2024
- AZI 12-03-2024
- Dividend Yield
- AGEN N/A
- AZI N/A
- EPS Growth
- AGEN N/A
- AZI N/A
- EPS
- AGEN N/A
- AZI N/A
- Revenue
- AGEN $160,427,000.00
- AZI $117,732,000.00
- Revenue This Year
- AGEN N/A
- AZI N/A
- Revenue Next Year
- AGEN $0.04
- AZI N/A
- P/E Ratio
- AGEN N/A
- AZI N/A
- Revenue Growth
- AGEN 59.00
- AZI 8.62
- 52 Week Low
- AGEN $2.50
- AZI $0.75
- 52 Week High
- AGEN $19.69
- AZI $4.05
- Technical
- Relative Strength Index (RSI)
- AGEN 28.17
- AZI N/A
- Support Level
- AGEN $2.50
- AZI N/A
- Resistance Level
- AGEN $2.89
- AZI N/A
- Average True Range (ATR)
- AGEN 0.29
- AZI 0.00
- MACD
- AGEN -0.07
- AZI 0.00
- Stochastic Oscillator
- AGEN 18.75
- AZI 0.00
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd is one of China's leading and fast-growing lifecycle automotive service providers. It provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels nationwide. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.